Learn

Neurology Research Review Issue 93 with commentary by Associate Professor Stacey Jankelowitz.  

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in Neurology. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au 

Details

In this edition we feature:

• Antisense oligonucleotide jacifusen for FUS-ALS
• Risk of dementia in patients with ED visits or hospitalisations due to cannabis
• Aspirin continuation vs discontinuation in surgically treated chronic subdural haematoma
• Visual perceptual learning digital therapy for visual field defects post stroke
• Fremanezumab for patients with migraine and comorbid major depressive disorder
• Validating the accuracy of PD clinical diagnosis
• Cost effectiveness of specialist physiotherapy for FMD
• Early vs late microvascular decompression for trigeminal neuralgia
• PD patients’ experiences with the foslevodopa/foscarbidopa pump
• Safety and efficacy of first-in-class NLX-112 in patients with PD 

 To access this publication please click ‘Enrol Now’ and you’ll be directed to  the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.